Subscribe to Dr. Meschino’s Free Newsletter

Subscribe Now


  1. DeFeudis FV (ed.), Ginkgo Biloba Extract (Egb 761): Pharmacological Activities and Clinical Application, Elsevier, Paris, 1991.
  2. Funfgeld EW (ed.), Rokan (Ginkgo Biloba): Recent Results in Pharmacology and Clinic, Sringer Verlag, NY, 1988
  3. Kleijenen J, Knipshcild P. Ginkgo Biloba. Lancet 1992;340:1136-9
  4. Kleijenen J, Knipschild P. Ginkgo Biloba for cerebral insufficiency. Br J Clin Pharmacol 1992;34:352-8
  5. Schaeffler VK, Reeh PW. Double-blind study of the hypoxia-protective effect of a standardized ginkgo biloba preparation after repeated administration in healthy volunteers. Arzneimittel-Forsch 1985;35:1283-6
  6. Chatterjee SS, Gabard B. Studies on the mechanism of action of an extract of ginkgo Biloba, A drug for the treatment of ischemic vascular diseases. Naunyn-Schmiedeberg’s Arch Pharmacol 1982;320(R52)
  7. Le Poncin et al. Effect of ginkgo biloba on changes induced by quantitative cerebral microembolization in rats. Arch Int Pharmacodyn Ther 1980;243:-44
  8. Karcher L, Zagerman P, Kriedlstein J. Effect of a n extract of ginkgo biloba on rat brain energy metabolism in hypoxia. Naunyn-Schmiedeberg’s Arch Pharmacol 1984;327:31-5
  9. Koltai M et al. Platelet activating factor (PAF): A review of its effects, antagonists and ossible future clinical implications (Part I). Drugs 1992;42(1):9-29
  10. Koltain M et al. Platelet activating factor (PAF): A review of its effects, antagonists and possible future clinical implications (Part II). Drugs 1991 42(2):174-204
  11. Schmidt U, Rabinovici K, Lande S. Einfluss eines ginkgo biloba specialekstraktes auf doe befomdlickeitbeizerebraler onsufficiziens. Muench Med Wochenschr 1991;133(suppl I):S15-18
  12. Bruchert E, Heinrich SE, Ruf-Kohler P. WirksamkeitvonL11370bei. Alterenpatienten mit himleistungsschwache: multizentrishe doppelblindstudie des fachverbandes deutscher allegemeinaezte. Muench Med Wochenschr 1991;133(Suppl 1):S9-114
  13. Meyer B. Etude multicentrique randomisee a double insu face au placebo due traitment des acouphenes per l’extrait de ginkgo biloba. Presse Med 1986;15:1562-4
  14. Taillandier J et al. Traitment des troubles du vidillissement cerebral pal L’extrait ginkgo biloba. Presse Med 1986;15:1583-7
  15. Haguenauer JP et al. Traitment des troubles de l’equilibre par l’extrait ginkgo biloba. Presse Med 1986;p1569-72
  16. Vorberg G, Schmidt U, Schenk N. Wirsamkeit eines neuen ginkgo biloba ekstraktes bei 100 patienten mi zerabraler insuffiziens. Herg Geffasse 1989;9:936-41
  17. Eckmann F, Himleistungsstorungen – Behandlung mit ginkgo biloba extract. Forsch Med 1990;108:557-60
  18. Wesnes K et al. A double-blind placebo-controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly. Hum Psychopharmacol 1987;2:159-69
  19. Gessner B, Voelp A, Klasser M. Study of the long-term action of a ginkgo biloba extract on vigilance and mental performance as determined by means of quantitative measurements. Arzneimittel Forsch 1985;35:1459-65
  20. Hofferberth B. Effect of ginkgo biloba extract on neurophysiological and psychometric measurement sin patients with cerebro-organic syndrome – A double-blind study versus placebo. Arzneimittel-Forsch 1989;39:918-22
  21. Hindmarch I, Subhan Z. The psychopharmacological effects of ginkgo biloba extract in normal healthy volunteers. Int J Clin Pharmacol Res 1984;4:89-93
  22. Lanthony P, Cosson JP. Evolution de la vision des couleurs dand la retinopathie diabetique debutante traitee par extrait de ginkgo bilova. J Fr Ophtalmol 1988;11:671-4
  23. Schneider B. Ginkgo biloba extract in peripheral arterial diseases: Meta-analysis of controlled clinical studies. Arzneimittel-Forsch 1992;42:428-36
  24. Thomson GL et al. A clinical trial of ginkgo biloba extract in patients with intermittent claudication. Int Angiol 1990;9:75-8
  25. Saudreau F et al. Efficacy of ginkgo biloba extract in the treatment of lower limb obliterative artery disease at stage III of the fontaine classification. J Mal Vasc 1989;14:177-82
  26. Rudofsky VG. The effect of ginkgo biloba extract in cases of arterial occlusive disease: A randomized placebo controlled double-blind crossover study. Forsch Med 1987;105:397-400
  27. Bauer U. Ginkgo biloba extract in the treatment of arteriopathy of the lower limbs: Sixty-five week study. Presse Med 1986;15:1546-9
  28. Bauer U. Six-month double-blind randomized clinical trial of ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency. Arzneimittel Forsch 1984;34:716-21
  29. Murray MT. The Healing Power of Herbs (2nd ed.) Prima Publishing 1995
  30. LeBars PL et al. A placebo-controlled double-blind randomized trial of an extract of ginkgo biloba for dementia. North American EGB Study Group. JAMA 1997;278(16):1327-32
  31. Oken BS et al. The efficacy of ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurology 1998;55(11):1409-15
  32. Braquet P. Anti-anaphylactic properties of BN 52021: A potent platelet activating factor antagonist. Advances in Experimental Medicine and Biology 1987;215:215-33
  33. Braquet P et al. Ethnopharmacology and the development of natural PAF antagonists as therapeutic agents. J Ethnopharmacol. April 1991;32(1-3):135-9
  34. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of ginkgo biloba extract. N Engl J Med. April 10 1997;336(15):p1108
  35. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology. June 1996;46(6):1775-6
  36. Kleijnen J et al. Ginkgo biloba. Lancet 1992;340(8828):1136-9
  37. White HL et al. Extracts of ginkgo biloba leaves inhibit monoamine oxidase. Life Sci 1996;58(16):1315-21
  38. Natural Product Encyclopedia. Biloba